Patent · US Active

Chemical compounds

US8129403B2 · kind B2 · utility

8Cited by

34References

14Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Michelle Lamb · Waltham, US
Tao Wang · Farmington, US
Dingwei Yu · Easton, US
Peter Mohr · Basel, CH
Bin Wang · Beijing, CN

Key dates

Filing date	Feb 15, 2006
Grant date	Mar 6, 2012
Priority date	—
Expiry date	Jan 13, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel compounds having the formula (I); and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.